The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world early outcomes of axicabtagene ciloleucel for relapsed or refractory (R/R) follicular lymphoma (FL).
 
Caron Alyce Jacobson
Honoraria - Abintus Bio; Bluebird Bio; Bristol-Myers Squibb; Celgene; Daiichi Sankyo/UCB Japan; Epizyme; ImmPACT-Bio; Instil Bio; Ipsen; Kite/Gilead; Lonza; Novartis
Consulting or Advisory Role - Abintus Bio; Bluebird Bio; Bristol-Myers Squibb; Celgene; Daiichi Sankyo/UCB Japan; Epizyme; ImmPACT-Bio; Instil Bio; Ipsen; Kite/Gilead; Lonza; Novartis
Research Funding - Kite, a Gilead company; Pfizer
 
Michael T. Hemmer
Employment - Kite, a Gilead company
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
 
Zhen-Huan Hu
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
 
Matthew Joshua Frank
Employment - Roche/Genentech (I)
Stock and Other Ownership Interests - Roche/Genentech (I)
Honoraria - Adaptive Biotechnologies; Kite/Gilead
Consulting or Advisory Role - CARGO Therapeutics; Kite, a Gilead company
Research Funding - Adaptive Biotechnologies; Allogene Therapeutics; Kite, a Gilead company (Inst)
 
Leslie Popplewell
Honoraria - ADC Therapeutics; Kite, a Gilead company
 
Nausheen Ahmed
No Relationships to Disclose
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Pfizer (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)
 
Timothy Best
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Sara Beygi
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Kite, a Gilead Company
Travel, Accommodations, Expenses - Kite, a Gilead Company
 
Harry H. Miao
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
 
Christine Fu
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Amgen; Gilead Sciences
Patents, Royalties, Other Intellectual Property - Cellares
 
Fang Sun
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
Research Funding - Gilead Sciences
 
Hairong Xu
Employment - Kite, a Gilead Company
 
Marcelo C. Pasquini
Honoraria - Celgene
Consulting or Advisory Role - Amgen; Medigene; Pfizer
Research Funding - Bristol-Myers Squibb; Kite, a Gilead Company; Novartis